Watchlist Price Alert

Agilent Technologies Inc. (A)

NYSE: A · Real-Time Price · USD

108.62

2.16 (2.03%)

At close: May 02, 2025, 3:59 PM

108.63

0.01%

After-hours: May 02, 2025, 05:34 PM EDT

2.03% (1D)

Bid	108.43
Market Cap	30.97B
Revenue (ttm)	6.53B
Net Income (ttm)	1.26B
EPS (ttm)	4.36
PE Ratio (ttm)	24.91
Forward PE	17.64
Analyst	Hold

Ask	110.25
Volume	898,644
Avg. Volume (20D)	2,133,967
Open	109.24
Previous Close	106.46
Day's Range	107.45 - 110.28
52-Week Range	96.43 - 155.35
Beta	1.19

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorpt...

Sector Healthcare

IPO Date Nov 18, 1999

Employees 17,900

Stock Exchange NYSE

Ticker Symbol A

Website https://www.agilent.com

Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for A stock is "Hold." The 12-month stock price forecast is $150.5, which is an increase of 38.56% from the latest price.

Stock Forecasts

Next Earnings Release

Agilent Technologies Inc. is scheduled to release its earnings on May 28, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-5.5%

Agilent Technologies shares are trading lower afte... Unlock content with Pro Subscription

2 months ago

+0.22%

Agilent Technologies shares are trading lower after the company issued FY25 adjusted EPS and Q2 guidance below estimates.

News

1 day ago · zacks.com

Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?

Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 days ago · seekingalpha.com

The Preferred Stock IPO Market Is Frozen

This month's preferred stock IPO market is frozen, dominated by “Par Cross” and “Insider Buying” alerts, reflecting investor uncertainty due to trade tensions. The trade war and tariffs have created s...

3 days ago · zacks.com

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

1 week ago · seekingalpha.com

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

City Office REIT's Series A Preferred Shares offer a tempting yield despite recent accounting losses and systemic pressures, suggesting a potential buying opportunity. The shares are cumulative, redee...

1 week ago · businesswire.com

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 i...

2 weeks ago · businesswire.com

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR certification for the use as a Compan...

3 weeks ago · zacks.com

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

3 weeks ago · https://thefly.com

Agilent placed on 'positive catalyst watch' at Citi

Citi analyst Patrick Donnelly added a "90-day positive catalyst watch" on shares of Agilent while keeping a Buy rating on the name with a $165 price target. At a time when investor sentiment on tools ...

4 weeks ago · seekingalpha.com

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-t...

1 month ago · businesswire.com

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T ther...

Load More News